natgillin/translations-raw huggingface dataset:
Diaré kvalme/opkastning, udspilet abdomen og oppustethed, forstoppelse, tørhed i munden, abdominale smerter og ubehag 
These included diarrhoea, abdominal pain, headache, nausea, chest pain and rash.
For at opnå den bedste behandling skal du være omhyggelig med at følge anvisningerne for CONTROLOC Control. 
In-process controls performed during the synthesis are suitable to control the reaction progress.
FARMAKOLOGISKE EGENSKABER 
Pharmacokinetics
I disse studier var procentdelen af de patienter, som opnåede fuldstændig lindring af halsbranden efter 7 dage, mellem 54,0% og 80,6 % i gruppen som blev behandlet med pantoprazol. 
In these studies between 57 and 78% of patients reported relief from heartburn at day 7 and 73-83% at day 14.
Endoskopisk helbredelse af GORD Fase I efter 8 ugers behandling 
Endoscopic healing of GORD Stage I after 8 weeks of treatment
Methacrylsyre-ethylacrylat copolymer (1:1) Natriumlaurilsulfat 
The gastro-resistant coating consists of methacrylic acid - ethyl acrylate copolymer 1:1; triethyl citrate is added as a plasticizer.
• BETINGELSER ELLER BEGRÆNSNINGER MED HENSYN TIL EN SIKKER OG 
• Risk and consequences of incorrect use
- Meget sjældne bivirkninger: 
Serious adverse drug reactions have therefore been rare.
Lindring af de vigtigste GORD-symptomer efter 28 dage 
Relief of key symptoms in GORD after 28 days
INFORMATION I BRAILLE-SKRIFT 
Baseline data
Derfor bør pantoprazol ikke gives sammen med atazanavir (se pkt. 
The co-administration with atazanavir is contra-indicated in the SPC and the Package Leaflet.
Lindring af halsbrand i GORD Fase I efter 1 og 2 
Relief of heartburn in GORD Stage I after 1 and 2 weeks of treatment
Det kan foreksempel være: 
Whereas:
Overtræk 
Comparator
4/8 uger 346 Pantoprazol og omeprazol var lige effektive 
346 Pantoprazole and omeprazole
Endoskopisk helbredelse af GORD Fase I efter 4 uger 
Endoscopic healing of GORD Stage I after 4 weeks
Endoskopisk helbredelse af GORD Fase I efter 4 ugers behandling 
Endoscopic healing of GORD Stage I after 4 weeks of treatment
Pantoprazol omdannes til dets aktive form, en cyklisk sulfonamid, i det sure miljø i parietalcellerne, hvor det hæmmer H+/K+-ATPase enzymet, dvs. det sidste stadie i produktionen af saltsyre i maven. 
It inhibits basal and stimulated acid secretion in animals and man via the covalent binding H+/K+ ATP-ase, also known as the “gastric proton pump” located in the secretory membrane of the parietal cell.
6.4 Særlige opbevaringsforhold 
2.7 Data exclusivity
Patienter med langvarige tilbagevendende symptomer på fordøjelsesbesvær eller halsbrand bør se deres læge med regelmæssige intervaller. 
Typically a patient with GORD symptoms sees a pharmacist in the first instance.
INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN 
• User consultation
338 Pantoprazol var bedre end ranitidin 
Pantoprazole was superior to ranitidine
CONTROLOC Control 20 mg enterotabletter Pantoprazol 
Pantozol 20 mg gastro-resistant tablets
Efter 7 dage var procentdelen af patienter, som opnåede fuldstændig lindring af syreregurgitation mellem 61,5% og 84,4%, efter 14 dage mellem 67,7% og 90,4%, og efter 28 dage mellem 75,2% og 
The results also show an early onset of the clinical effect, with rates of complete relief of heartburn between 54.0% and 80.6% achieved after 7 days of treatment with pantoprazole 20 mg. A further improvement in the symptom relief rates was observed after 14 days and 28 days of treatment, respectively.
Povidon K90 
WA300
Lever og galdeveje 
Relief of GORD
SÆRLIGE OPBEVARINGSBETINGELSER Opbevares i den originale pakning for at beskytte mod fugt. 
The tablets stored in primary packaging materials as described in the dossier were in compliance with the shelf-life specifications at all tested time points.
Amning 
Randomisation
I en retrospektiv analyse af 17 studier med 5960 patienter med gastroøsofageal refluks (GORD), som blev behandlet med 20 mg pantoprazol som monoterapi, blev de symptomer, der er forbundet med syre refluks, f.eks halsbrand og syre regurgitation, evalueret i henhold til en standardiseret metode. 
Results of 17 randomized controlled clinical studies (i.e. two pivotal and 15 supportive studies), in which pantoprazole 20mg was investigated with regard to relief of reflux symptoms as a primary or secondary endpoint, have been presented.
B. BETINGELSER FOR MARKEDSFØRINGSTILLADELSEN 
• Post marketing experience
Det kan give symptomer som smertefuld brændende fornemmelse i brystet, som stiger op i halsen (halsbrand) og giver en sur smag i munden (sure opstød). 
Heartburn was defined as burning feeling rising from the stomach or lower chest up towards the neck.
INSTRUKTIONER VEDRØRENDE ANVENDELSEN 
BACKGROUND INFORMATION ON THE PROCEDURE
De prækliniske data viser ingen særlig risiko for mennesker vurderet ud fra konventionelle undersøgelser af sikkerhedsfarmakologi, toksicitet efter gentagne doser og genotoksicitet. 
Clinical trial data did not indicate any specific safety issue in this patient population and the oral prescriptiononly product is approved for adolescent patients.
Dosis bør ikke overskrides. 
No dose adjustment is required in the elderly.
4.4 Særlige advarsler og forsigtighedsregler vedrørende brugen 
2.8 Overall conclusions, risk/benefit assessment and recommendation
Farmakoterapeutisk klassifikation: Protonpumpehæmmere, ATC-kode: A02BC02 
Table 5 Relief rate of acid eructation in study BGI022
Kerne 
n
Samtidig fødeindtagelse har ingen indflydelse på biotilgængeligheden (AUC eller Cmax), men øger variationen i lag-time (tlag). 
Concomitant intake of food has no influence on the bioavailability of pantoprazole.
Særlige patientgrupper 
• Clinical studies in special populations
Lindring af de vigtigste GORD-symptomer efter 14 dage 
Relief of key symptoms in GORD after 14 days
En usædvanlig stor forøgelse forekommer imidlertid kun i enkeltstående tilfælde. 
A continuously high level of quality can therefore be guaranteed.
Tag den næste dosis næste dag til sædvanlig tid. 
The effect increases with dose and over time and reaches steady state after a few days.
Virkning og anvendelse 
Outcomes and estimation
DATO FOR ÆNDRING AF TEKSTEN 
1.1 Submission of the dossier
• ANDRE BETINGELSER 
• Adverse events
Batch 
CH2
INFORMATION I BRAILLE-SKRIFT CONTROLOC Control 20 mg 
CONTROLOC Control is available in film coated tablets containing 20 mg pantoprazole.
Bivirkninger, der er observeret ved brug af pantoprazol i kliniske studier og efter markedsføringen. 
These studies, which reflect the use of the product in medical practice as compared to the scientific setting of clinical studies with strict inclusion and exclusion criteria, contributed to the safety profile of pantoprazole.
Absorption 
Allocation
Nedsat leverfunktion 
Active Substance
Indgivelsesmåde 
Introduction
Lindring af GORDsymptomer efter 7 og 28 dages behandling 
symptoms after 7 and 28 days of
Patienterne bør konsultere deres læge inden de tager dette lægemiddel, hvis de skal have foretaget en endoskopi eller urea udåndingstest. 
In this trial, patients were entered based on the presence of reflux symptoms without endoscopic examination.
Synsforstyrrelser/ sløret syn 
Subjects by arm entered/ completed
Resultater Bemærkninger 
Outcomes/endpoints
Derfor bør patienter, der er i behandling med kumarinantikoagulantia (f.eks. phenprocoumon eller warfarin), have foretaget ekstra analyser af prothrombintid/INR ved behandlingsstart og -ophør samt ved uregelmæssig brug af pantoprazol. 
Patients with conditions for whom a nonprescription use of pantoprazole would not be appropriate, like patients with current erosive lesions of the upper gastrointestinal tract (e.g. reflux esophagitis stage I-V, erosive gastritis, were excluded.
Hypromellose 
Pharmacodynamics
Selv om hovedmetabolitten har en længere halveringstid (2-3 timer), er udskillelsen stadig hurtig, og akkumulation finder således ikke sted. 
Since the elimination half-life in these patients is still shorter than the dosing interval of 24 hours, no accumulation of pantoprazole was observed following multiple dosing.
Der er ingen kendte symptomer på overdosering hos mennesker. 
No further information on the contraindicated symptoms or the consequences of the treatment is available.
CONTROLOC Control bruges til korttidsbehandling af reflukssymptomer (f.eks. halsbrand og sure opstød) hos voksne. 
The claimed indication at time of application read as follows: “Treatment of reflux symptoms (e.g. heartburn, acid regurgitation)”
Chokolade, pebermynte, spearmint, fed og friturestegt mad, syreholdig mad, krydret mad, 
Placebocontrolled, multicenter, randomized, double blind, parallel group comparison
Virkningsmekanisme 
Risk Management Plan
Indehaver af markedsføringstilladelsen Nycomed GmbH 
The initial application was submitted by Nycomed GmbH (EMEA/H/C/1013).
6.3 Opbevaringstid 
2.6 Legal Status
Specielt patienter over 55 år, som dagligt tager ikkereceptpligtige lægemidler mod fordøjelsesbesvær og halsbrand, bør informere deres apotek eller læge. 
Since in patients with liver cirrhosis the elimination half-life, the AUC and the maximum serum concentration is increased compared to healthy subjects, patients with liver disease should not be supplied with non-prescription pantoprazole without consulting a doctor.
Trombocytopeni, leukopeni, 
Thrombocytopenia very rare
Rød jernoxid (E 172) Sort jernoxid (E 172) Gul jernoxid (E 172) Sojalecithin Titandioxid (E 171) Antifoam DC 1510 
74.3% to 92.3% H2RA (Ranitidine 300mg, Ranitidine 2x150 mg, Nizatidine 2x150 mg)
ANDET 
ITT
- hvis du tidligere har haft et mavesår eller har fået foretaget en maveoperation - hvis du har leverproblemer eller gulsot (gulfarvning af huden og øjnene) - hvis du regelmæssigt tager til læge på grund af alvorlige sygdomme eller lidelser 
Indirect danger may arise by masking any serious underlying conditions such as an upper gastrointestinal tumour or myocardial infarction if the patient erroneously assesses his or her symptoms (with the help of the pharmacist as appropriate) as caused by gastro-oesophageal reflux.
Du kan få CONTROLOC Control uden recept. 
from prescription to non-prescription.
Virkningen er den samme, uanset om det aktive stof gives oralt eller intravenøst. 
The synthesis of the drug substance is performed without optically active reagents and results in a racemate.
Den mekanisme, der fører til, at substituerede benzimidazoler giver ventrikelcancer er undersøgt nøje og konklusionen er, at ventrikelcancer er en sekundær reaktion til den kraftige forøgelse af serumgastrinniveauet hos rotter i kronisk højdosisbehandling. 
The results of clinical studies where symptomatic relief of GORD was investigated show that pantoprazole provides relief of heartburn and acid regurgitation during a short-term treatment course (2-4 weeks).
Selv om der ikke er set interaktion ved samtidig anvendelse af phenprocoumon eller warfarin i kliniske farmakokinetiske forsøg, er der rapporteret om få isolerede tilfælde af ændringer i INR ved samtidig behandling efter markedsføringen. 
No increased risk of the treatment with pantoprazole in patients with renal impairment or impaired liver function has been detected in the post-marketing period.
Tag ikke CONTROLOC Control samtidigt med anden medicin, som begrænser mængden af syre i din mave, så som andre syrepumpehæmmere (omeprazol, lansoprazol eller rabeprazol) eller en H2antagonist (f.eks. ranitidin, famotidin). 
Reflux of gastric acid into the oesophagus is mediated by different mechanisms such as transient lower oesophageal sphincter relaxations or reduced pressure, impaired oesophageal clearance and hiatus hernia.
Dannelse af carcinoide forstadier (atypisk hyperplasi) og ventrikelcarcinoider, som er fundet i dyreforsøg, er ikke set hos mennesker i langtidsbehandling i de hidtil udførte studier (se pkt. 
It involves conventional chemical operations (alkylation, oxidation, formation of salt), which were transferred from laboratory to production batches during the development.
Du skal kontakte lægen, hvis du ikke oplever symptomlindring efter 2 hele ugers behandling med medicinen. 
Additionally, patients with symptoms related to conditions other than GORD will not experience improvement after 2 weeks of treatment or they will need longer than 4-week treatment and therefore will see a doctor.
4/8 uger 331 
7.3% to 44.1% 6/7
Patienterne bør rådgives om, at tabletterne ikke er beregnet til at give øjeblikkelig lindring. 
Patients with chest pain will be excluded from non-prescription supply.
Titandioxid (E 171) 
Randomised (n=361)
Du må gerne tage CONTROLOC Control samtidig med syreneutraliserende medicin (f.eks. magaldrat, alginsyre, natriumbicarbonat, aluminiumhydroxid, magnesiumcarbonat eller kombinationer heraf), hvis det er nødvendigt. 
Pantoprazole-containing products are currently licensed throughout the European community for the treatment of conditions such as gastro-oesophageal reflux disease, Zollinger-Ellison syndrome, acid reflux disease, dyspepsia and duodenal or gastric ulcers.
Hyperlipidæmi og forhøjede lipider (triglycerider, cholesterol), ændring i kropsvægt 
Normal oesophagus on endoscopy History of reflux symptoms (heartburn, acid eructation, pain on swallowing)
BATCHNUMMER 
Numbers analysed
Pantoprazol metaboliseres i leveren via cytokrom P450 enzymsystemet. 
formulations of pantoprazole have equipotent effect on intragastric pH.
MARKEDSFØRINGSTILLADELSEN VEDRØRENDE UDLEVERING OG BRUG Lægemidlet er ikke receptpligtigt. 
The safety profile of pantoprazole is established and allows the assessment according to the applicable criteria for non-prescription medicines.
CONTROLOC Control kan medføre, at andre lægemidler ikke virker ordentligt. 
Non-responders to acid suppression could indicate the role of other factors.
Inden for dosisintervallet 10-80 mg er pantoprazols plasmakinetik lineær efter både oral og intravenøs administration. 
Unlike other proton pump inhibitors, pantoprazole has linear pharmacokinetics in a dose range of 10 - 80mg.
Patienter bør instrueres i at kontakte lægen, hvis: 
Patients with new symptoms will be referred to a doctor.
Gul jernoxid (E 172) 
PP (N=268)
Fremstiller 
Studies
Desuden blev der fundet planocellulære papillomer i formaven på rotter. 
Tablet cores are produced by wet granulation.
De følgende bivirkninger er blevet rapporteret ved brug af pantoprazol. 
The efficacy of pantoprazole in the proposed indication and posology has been demonstrated.
Denne indlægsseddel blev senest godkendt 
This was considered acceptable.
Øjne 
Visit
Telefon: 
Rapporteur:
Synsforstyrrelser så som sløret syn; ledsmerter; muskelsmerter; ændringer i kropsvægt; forhøjet kropstemperatur; hævelse af hænder og fødder; allergiske reaktioner; depression; forhøjede værdier af bilirubin og fedt i blodet (kan ses i blodprøver). 
anaphylactic reaction and anaphylactic shock) Depression (and all aggravations) Urticaria Weight changes Arthralgia Myalgia Bilirubin increased Oedema peripheral Body temperature increased Angioedema Leukopenia very rare
Udløbsdatoen (Exp) er den sidste dag i den nævnte måned. 
The dissolution test is the same as the one used during drug development.
Hepatocellulær skade, gulsot, leversvigt 
4 weeks Rather severe heartburn, acid regurgitation, pain on swallowing
I tilfælde af overdosering med kliniske tegn på forgiftning, bortset fra symptomatisk og understøttende behandling, kan der ikke gives nogle særlige terapeutiske anbefalinger. 
All analytical methods, except for particle size and residual solvents, are compendial and validation of these methods was not deemed necessary.
I nedenstående tabel er bivirkningerne ordnet efter følgende frekvensklassifikation: 
Tablets cores covered with subcoating are subsequently covered with the second coating layerenteric coating.
Arthralgi, Myalgi 
Pantoprazole: Esomeprazole:
Pædiatrisk anvendelse 
• Patient exposure
Behandling med syrehæmmende midler medfører en let forøget risiko for gastrointestinale infektioner forårsaget af bakterier, som f.eks. 
Pantoprazole is indicated for a range of acid-related gastrointestinal disorders.
Forhøjede leverenzymer (transaminaser, γ-GT) 
Placebo Relief Rate of Acid Eructation (N/Total N)
Da pantoprazol i stor udstrækning er proteinbundet, er det ikke let dialyserbart. 
Given that there are no direct safety issues that preclude pantoprazole being available as a non-prescription medicine this supply classification is considered of benefit to the patients.
- Øvrige indholdsstoffer: 
The chosen reference product is:
De fleste patienter vil opnå symptomfrihed af halsbrand og sure opstød indenfor en uge. 
The majority of patients with reflux symptoms can be controlled at the self-care level or a primary care level.
I de udvalgte studier skulle der være registreret mindst ét syrereflukssymptom inden for 2 uger. 
All patients who received at least one study medication dose were included into the safety analysis.
Distribution Fordelingsvolumet er på omkring 0,15 l/kg og serumproteinbindingen er ca. 98%. 
The level of significance adopted was 0.05 and the test power was 90% for a two-tailed test.
I dyreforsøg (rotter) var den observerede NOAEL (intet bivirkningsniveau observeret) 5 mg/kg for embryotoksicitet. 
Although spontaneous abortions and premature births did not occur with higher frequency, because animal studies have shown reproductive toxicity (signs of slight fetotoxicity were observed at doses above 5 mg/kg), patients are advised not to use pantoprazole during pregnancy.
Urticaria, angioødem 
Pantoprazole: Ranitidine:
I toårs studierne med gnavere blev der observeret et øget antal af levertumorer hos rotter (kun i et rottestudie) og hos hunmus, hvilket blev tolket som en konsekvens af pantoprazols høje metaboliske omsætning i leveren. 
The majority of these studies were performed in mild reflux disease and investigated the efficacy of pantoprazole either in the symptomatic relief or in the endoscopic healing of GORD.
Yderligere information om dette lægemiddel er tilgængelig på Det europæiske Lægemiddelagenturs (EMEAs) hjemmeside http://www.emea.europa.eu/. 
The eligibility for this multiple application to the centralised procedure was agreed upon by the EMEA/CHMP.
MÆRKNING, DER SKAL ANFØRES PÅ DEN INDRE EMBALLAGE KARTONFORSTÆRKNING 
The printed tablets are put into the container closure systems.
Forekomsten af disse neoplastiske ændringer hænger sammen med de pantoprazol-inducerede forandringer i nedbrydning af thyroxin i rotteleveren. 
Stable salts are only formed with bases, due to rapid conversion to the cyclic sulphenamide on pyridyl protonation.
Blæk til prægning: Shellac; rød, sort og gul jernoxid (E 172); sojalecithin, titandioxid (E 171), antifoam DC 1510. 
1 FENDRICK AM et al., Self-Selection and Use Patterns of Over-the-Counter Omeprazole for Frequent Heartburn, Clinical Gastroenterology and Hepatology 2004;2:17-21
LISTE OVER HJÆLPESTOFFER Indeholder sojalecithin. 
The manufacturing process of pantoprazole sodium sesquihydrate is a four step synthesis.
Gul, oval, bikonveks filmovertrukken enterotablet påtrykt ”P20” med brunt blæk på den ene side. 
In the final step the gastro-resistant tablets are printed on one side [“P20﻿ with brown printing ink using an offset printing machine.
Tid, der går, inden de vigtigste GORDsymptomer er forsvundet 
Time to freedom from key GORD symptoms
Den lille stigning i AUC og Cmax hos ældre forsøgspersoner i forhold til yngre har ingen klinisk relevans. 
Clinical studies in elderly patients and in patients with liver or kidney disease did not identify any concerns.
Det er uvist, om pantoprazol udskilles i modermælk hos mennesker. 
It is noted that specific aspects of the national implementation of a nonprescription status vary amongst Member States.
Passagen over placenta hos rotter blev undersøgt og fandtes at stige med fremskreden graviditet. 
Test product and placebo tablets were of identical appearance, and were packed in identical bottles and cartons.
Stevens-Johnson syndrom, Lyell syndrome, erythema multiforme, lysfølsomhed 
randomized, doubleblind, multicenter, parallel group comparison
Der er i specifikke undersøgelser ikke fundet klinisk betydningsfulde interaktioner med carbamazepin, caffein, diazepam, diclofenac, digoxin, ethanol, glibenclamid, metoprolol, naproxen, nifedipin, phenytoin, piroxicam, theofyllin og et oralt kontraceptivum indeholdende levonorgestrel og ethinylestradiol. 
The product specification is standard for tablets (modified release) and contains tests with suitable limits for appearance, mean mass, disintegration time, loss on drying, identification, dissolution (UV determination), content uniformity, assay (HPLC), purity - impurities and degradation products (HPLC), microbial limits.
Alle faktorer, der nedsætter surhedsgraden i maven, - inklusiv protonpumpehæmmere - øger antallet af de bakterier, der normalt findes i mavetarmkanalen. 
As reflux symptoms are common and can affect the quality of life of the majority of sufferers a proton pump inhibitor is usually used as a first-line treatment.
Triethylcitrat 
Placebo
Det kan være nødvendigt at tage tabletterne i 2-3 på hinanden følgende dage for at opnå en forbedring af symptomerne. 
Mild symptoms occurring 2 or more days per week or moderate to severe symptoms occurring more than 1 day per week are often considered troublesome for patients.
Organsystem 
Statistical methods
Det er vist, at samtidig anvendelse af atazanavir 300 mg/ ritonavir 100 mg og omeprazol (40 mg én gang daglig) eller atazanavir 400 mg og lanzoprazol (60 mg givet som enkeltdosis) hos raske forsøgspersoner har medført en betydelig reduktion i atazanavirs biotilgængelighed. 
Comparison of clinical safety and efficacy of 20mg, 40mg pantoprazole QD and nizatidine 150mg BID in symptomatic erosive oesophagitis
• de har utilsigtet vægttab, anæmi, gastrointestinal blødning, dysphagi, vedvarende opkastninger eller opkastning med blod, da det kan sløre symptomerne og derved forsinke en diagnose af en alvorlig lidelse. 
However, patients with alarming symptoms indicative of gastrointestinal malignancy (such as unintentional weight loss, bleeding, dysphagia, abdominal pain etc.) will normally see a physician.
Frekvens 
METHODS
På grund af den specifikke binding af pantoprazol til protonpumperne i de parietale celler svarer halveringstiden for udskillelsen ikke til den meget længere virkningsvarighed (hæmning af syresekretionen). 
The null hypothesis that no difference in efficacy exists between the two treatments was tested one-sided versus the alternative that such a difference exists (superiority of pantoprazole).
Der forventes ingen bivirkninger i skjoldbruskkirtlen, da den terapeutiske dosis hos mennesker er lav. 
However, in the nonprescription setting the presence of oesophageal erosions cannot be ruled out because treatment will be performed without prior endoscopic examination.
LÆGEMIDLETS NAVN CONTROLOC Control 20 mg, enterotabletter 
Pantozol 40 mg gastro-resistant tablets
Der kan være lokale retningslinjer for bortskaffelse. 
There may be local guidelines for disposal.
Thousand Oaks, Californien 
Thousand Oaks, California
Ikke kendt (hyppigheden kan ikke vurderes ud fra tilgængelige data) 
Not known (frequency cannot be estimated from available data)
HRa CI 95% for HRa 
CI 95% for HRa
Injektionen tager cirka 10 sekunder. 
Your injection could take about 10 seconds.
Kontakt straks din læge. 
Call your doctor immediately.
- Udløbsdatoen, der er trykt på etiketten, er passeret. 
- The expiration date printed on the label has passed.
Bliv ved med at trykke ned på huden. 
Keep pushing down on your skin.
En del af en multipakning; kan ikke sælges separat. 
Component of a multipack, can't be sold separately.
- En eller flere dele ser ud til at være revnede eller ødelagte. 
- Any part appears cracked or broken.
● Tal med din læge eller apotekspersonalet om korrekt bortskaffelse. 
● Talk with your doctor or pharmacist about proper disposal.
AMGEVITA kan også anvendes alene. 
AMGEVITA can also be given alone.
Beslutningen om at stoppe med at bruge AMGEVITA skal diskuteres med din læge. 
The decision to stop using AMGEVITA should be discussed with your doctor.
Dun Laoghaire, Co Dublin Irland 
Dun Laoghaire, Co Dublin Ireland
Resultater fra den samlede UC-II studiespopulation er vist i tabel 28. 
Results from the overall UC-II study population are shown in table 28.